UNH · 10-Q · 2026Q2 · Full report

Liquidity and Cash Position

UNITEDHEALTH GROUP INC · 2026-08-10 · Importance 69 · Surprise 64 · No source text

Operating cash flow increased $7.320 billion to $19.964 billion for the six months ended June 30, 2026, driven by higher earnings, government payment timing, working capital, and Inflation Reduction Act pharmacy rebate changes. Cash, cash equivalents, available-for-sale debt securities, and marketable equity securities totaled $81.0 billion, including $28.6 billion of cash and cash equivalents at June 30, 2026. Only $1.1 billion of cash and cash equivalents was available for general corporate use, while loan receivables totaled $10.8 billion. The Company repaid $4.813 billion of short- and long-term debt and spent $1.562 billion on property, equipment, and capitalized software.

Key facts

• For the six months ended June 30, 2026, cash provided by operating activities: $19,964 million compared to $12,644 million in 2025 (increase of $7,320 million); total sources of cash for six months ended June 30, 2026: $22,142 million versus $17,520 million in 2025 (increase of $4,622 million). source
• Cash flows from operations for the six months ended June 30, 2026 were $20.0 billion. source
• As of June 30, 2026, cash, cash equivalents, available-for-sale debt securities and marketable equity securities balances: $81.0 billion, including approximately $28.6 billion of cash and cash equivalents (of which $1.1 billion was available for general corporate use), $50.3 billion of debt securities and $2.1 billion of investments in marketable equity securities. source
• UnitedHealth reported increased cash received from dispositions and other strategic transactions of $1,091 million in the six months ended June 30, 2026. source
• Available-for-sale debt securities portfolio weighted-average duration as of June 30, 2026: 4.1 years and weighted-average credit rating of "Double A." source

Impact estimates